Literature DB >> 23828653

Typical fibrolamellar hepatocellular carcinoma in a Japanese boy: report of a case.

Masanori Matsuda1, Hidetake Amemiya, Hiromichi Kawaida, Hirotaka Okamoto, Naohiro Hosomura, Masami Asakawa, Katsuhiro Sano, Utaroh Motosugi, Tomoaki Ichikawa, Tadao Nakazawa, Hideki Fujii.   

Abstract

We report a case of typical fibrolamellar hepatocellular carcinoma (FL-HCC) in a 16-year-old Japanese boy. This is very rare malignancy in Japan. The patient was referred for investigation of a large hepatic tumor and the results of tests for hepatitis B virus surface antigen and hepatitis C virus antibody were negative. Liver function test results and serum alpha-fetoprotein (AFP) levels were normal; however, the prothrombin induced by vitamin K absence/antagonist II was elevated. Computed tomography (CT) showed a large lobulated heterogeneously enhanced tumor in the posterior section of the liver. We diagnosed FL-HCC and performed posterior sectionectomy of the liver. The resected specimen contained a light brown and green tumor with a central fibrous scar, 10.0 cm in diameter. Microscopic and electron microscopic examinations revealed the typical features of FL-HCC. Immunohistochemically, the tumor cells were positive for cytokeratin (CK) 7, but negative for CK19 and AFP. The patient was alive without recurrence 48 months after surgery. Following this case report, we summarize the clinical features of the Japanese cases documented in the literature.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23828653     DOI: 10.1007/s00595-013-0653-y

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  23 in total

1.  Fibrolamellar hepatocellular carcinoma: an immunohistochemical comparison with conventional hepatocellular carcinoma.

Authors:  Hala M Abdul-Al; Guanghua Wang; Hala R Makhlouf; Zachary D Goodman
Journal:  Int J Surg Pathol       Date:  2010-05-05       Impact factor: 1.271

2.  Clinicopathologic features and survival in fibrolamellar carcinoma: comparison with conventional hepatocellular carcinoma with and without cirrhosis.

Authors:  Sanjay Kakar; Lawrence J Burgart; Kenneth P Batts; Joaquin Garcia; Dhanpat Jain; Linda D Ferrell
Journal:  Mod Pathol       Date:  2005-11       Impact factor: 7.842

3.  Fibrolamellar hepatocellular carcinoma: imaging and pathologic findings in 31 recent cases.

Authors:  T Ichikawa; M P Federle; L Grazioli; J Madariaga; M Nalesnik; W Marsh
Journal:  Radiology       Date:  1999-11       Impact factor: 11.105

4.  Bile canaliculi-like lumina in fibrolamellar carcinoma of the liver: a light- and electron-microscopic study and three-dimensional examination of serial sections.

Authors:  S Sato; T Masuda; H Oikawa; R Satodate; K Suzuki; S Sato; A Suzuki; N Monma
Journal:  Pathol Int       Date:  1997-11       Impact factor: 2.534

5.  Outcome of liver resection and transplantation for fibrolamellar hepatocellular carcinoma.

Authors:  G El-Gazzaz; W Wong; M K El-Hadary; B K Gunson; D F Mirza; A D Mayer; J A Buckels; P McMaster
Journal:  Transpl Int       Date:  2000       Impact factor: 3.782

6.  Hepatic resection versus transplantation for hepatocellular carcinoma.

Authors:  S Iwatsuki; T E Starzl; D G Sheahan; I Yokoyama; A J Demetris; S Todo; A G Tzakis; D H Van Thiel; B Carr; R Selby
Journal:  Ann Surg       Date:  1991-09       Impact factor: 12.969

7.  Typical fibrolamellar hepatocellular carcinoma in Japanese patients: report of two cases.

Authors:  J Tanaka; N Baba; S Arii; K Fujita; J Tamura; Y Kawakami; S Tsuji; M Imamura; H Yamabe; S Nakai
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

8.  Fibrolamellar carcinoma of the liver: a tumor of adolescents and young adults with distinctive clinico-pathologic features.

Authors:  J R Craig; R L Peters; H A Edmondson; M Omata
Journal:  Cancer       Date:  1980-07-15       Impact factor: 6.860

9.  Unique phenotype of hepatocellular cancers with exon-3 mutations in beta-catenin gene.

Authors:  Benjamin Cieply; Gang Zeng; Tracy Proverbs-Singh; David A Geller; Satdarshan P S Monga
Journal:  Hepatology       Date:  2009-03       Impact factor: 17.425

Review 10.  Case report: fibrolamellar hepatocellular carcinoma in a Japanese woman: a case report and review of Japanese cases.

Authors:  H Hoshino; N Katada; D Nishimura; J Imada; K Morita; N Yoshida; H Sano; K Okamoto; K Kato
Journal:  J Gastroenterol Hepatol       Date:  1996-06       Impact factor: 4.029

View more
  3 in total

1.  Metastatic Fibrolamellar Hepatocellular Carcinoma to the Pancreas.

Authors:  Nicolas A Villa; Rahul Pannala; Douglas O Faigel; Danielle J Haakinson; Nitin Katariya; Ramesh Ramanathan; Dawn Jaroszewski; Thomas K Lidner; Thomas Byrne
Journal:  Case Rep Gastroenterol       Date:  2015-07-29

2.  Imaging features of fibrolamellar hepatocellular carcinoma in gadoxetic acid-enhanced MRI.

Authors:  Viktoria Palm; Ruofan Sheng; Philipp Mayer; Karl-Heinz Weiss; Christoph Springfeld; Arianeb Mehrabi; Thomas Longerich; Anne Katrin Berger; Hans-Ulrich Kauczor; Tim Frederik Weber
Journal:  Cancer Imaging       Date:  2018-03-01       Impact factor: 3.909

3.  Hepatocellular Carcinoma, Fibrolamellar Variant: Diagnostic Pathologic Criteria and Molecular Pathology Update. A Primer.

Authors:  Consolato M Sergi
Journal:  Diagnostics (Basel)       Date:  2015-12-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.